This bill amends the CARES Act by removing subsection (c) of Section 4024. It does not create new policies or directly affect any specific group; it only modifies an existing provision in federal law. The change is purely procedural, eliminating a specific subsection without altering the law's overall structure or requirements. No new rules or impacts on housing are introduced. (1 sentence, as it is a procedural amendment).
This bill prohibits federal tax deductions or credits for businesses involved in marijuana trafficking, maintaining the current tax treatment under Section 280E of the Internal Revenue Code. It directly affects businesses operating in the legal marijuana industry (where permitted by state law) by preventing them from deducting ordinary business expenses like rent or supplies on federal tax returns. The key provision expands the existing rule to explicitly include marijuana trafficking under federal law, regardless of state legalization. This policy change means marijuana businesses cannot use standard business expense deductions for federal tax purposes, aligning with federal prohibition on marijuana.
This bill permanently extends the New Markets Tax Credit (NMTC) program, which incentivizes private investment in low-income communities. It modifies the tax code to keep the credit available beyond 2025 (replacing "2020 through 2025" with "2020 and each calendar year thereafter") and adds automatic annual inflation adjustments to the credit amount starting in 2026. The bill also provides tax relief by allowing NMTC credits to offset the alternative minimum tax, specifically for investments made after December 2024. This directly affects community development financial institutions (CDFIs) and investors who fund projects in designated low-income areas.
S 475, the Alternatives to PAIN Act, changes Medicare Part D coverage to make non-opioid pain management drugs more accessible and affordable for beneficiaries. It requires Medicare plans to cover qualifying non-opioid pain drugs without deductibles and place them on the lowest cost-sharing tier (meaning patients pay the least out-of-pocket) starting in 2026. The bill also prohibits plans from requiring step therapy (forcing patients to try opioids first) or prior authorization for these specific drugs. Qualifying drugs must treat acute pain (like post-surgery), not work on opioid receptors, have no equivalent alternatives, and meet cost thresholds. This directly affects Medicare Part D beneficiaries needing pain management and the plans that cover them.
This bill (S 482) adds Czechia to the list of countries whose business traders can enter the U.S. as E-1 nonimmigrants, provided Czechia offers similar status to U.S. nationals. It directly affects Czech businesspeople seeking to operate trade in the U.S. and U.S. citizens needing reciprocal treatment in Czechia. The key provision modifies the Immigration and Nationality Act to include Czechia as a qualifying country if the Czech government grants comparable business visitor status to U.S. citizens. This change would allow Czech nationals to access E-1 visa benefits for conducting trade, contingent on Czechia’s reciprocal policy. The bill focuses solely on updating eligibility criteria without altering broader immigration rules.
HR 1086, the Agriculture Export Promotion Act of 2025, increases funding for two key U.S. Department of Agriculture export programs to boost agricultural trade. It raises the Market Access Program budget from $255 million to $489.5 million annually and doubles the Foreign Market Development Cooperator Program base funding from $200 million to $400 million, with cooperator funding increasing from $34.5 million to $69 million. These changes, effective through 2029, address years of stagnant funding while aiming to counter competitive disadvantages from foreign agricultural export programs. The bill directly supports U.S. agricultural producers - from apple growers to seafood exporters - by expanding access to international markets through these programs.
This bill requires manufacturers to include a unique physical or chemical identifier on each pill of certain controlled substances in solid oral dosage form (like tablets or capsules). It directly affects pharmaceutical companies producing these specific medications, mandating the identifier to be added to every dose manufactured five years after the bill's enactment. The identifier must be machine-readable and help verify the product's authenticity throughout the supply chain. This change aims to improve tracking and combat counterfeit drugs in the distribution system.
This bill allows a national of the Czech Republic to qualify for E-1 nonimmigrant status if the Czech Republic provides similar nonimmigrant status to U.S. nationals. E-1 classification allows nationals of certain countries (i.e., those with a treaty of commerce and navigation with the United States, those under a qualifying international agreement, or those deemed to qualify through statute) to be admitted solely to engage in international trade, along with their families and employees.
Protect Our Letter Carriers Act of 2025 This bill requires or authorizes certain actions related to the U.S. Postal Service (USPS). The bill requires the Department of Justice to appoint an assistant U.S. attorney in each judicial district to coordinate and supervise the investigation and prosecution of various crimes related to postal services (for example, assault on a postal service employee, breaking into a post office, or obstruction of mails). The bill also requires the U.S. Sentencing Commission to amend sentencing guidelines to provide that the assault or robbery of a postal employee shall be treated the same as the assault of a law enforcement officer. Additionally, the bill authorizes appropriations for the USPS to install high security collection boxes and replace older versions of the universal mailbox key with electronic versions.
HR 1046, the Marc Fischer Memorial Act, requires the Bureau of Prisons to implement digital mail scanning technology at all federal prisons to detect fentanyl and other synthetic drugs in inmate mail. It mandates a strategy within 90 days of an evaluation, including 100% scanning of all mail, digital copies of mail to inmates within 24 hours, and physical mail delivery within 30 days for non-contaminated items. The bill directly affects federal prison staff, inmates, and the Bureau of Prisons by aiming to reduce drug-related overdoses and alleviate staff workload tied to mail processing. Implementation must be completed within three years, with annual reports tracking detected drugs and strategy efficiency. The legislation focuses on concrete technological and procedural changes to enhance safety, referencing a successful pilot program at two facilities.
This bill permanently extends the New Markets Tax Credit (NMTC), a federal tax incentive that encourages private investment in low-income communities. It directly affects community development entities (CDEs) that channel capital into underserved neighborhoods for projects like housing, healthcare, and businesses. Key provisions include permanently extending the credit beyond 2025, adding annual inflation adjustments to the credit amount starting in 2026, and ensuring the credit isn't reduced by the alternative minimum tax for investments made after December 2024. The changes apply to taxable years beginning after December 2024, providing long-term stability for community development financing.
HR 1102 establishes a commission to study the feasibility of creating a National Museum of Italian American History and Culture in Washington, D.C. The commission, composed of 8 members appointed by congressional leaders, will examine factors like location options, costs, fundraising potential, and impacts on existing museums, and must report back within 18 months. It will not create the museum itself but will develop recommendations for Congress on whether to proceed, with all funding coming from private sources - no federal funds may be used for the commission’s work. The bill focuses solely on the study process, not on building or operating the museum.
